Literature DB >> 29270886

Comparison of the Adult ADHD Self Report Scale Screener for DSM-IV and DSM-5 in a Dually Diagnosed Correctional Population.

Leo Bastiaens1, James Galus2.   

Abstract

The diagnosis of Attention Deficit Hyperactivity Disorder in adults with Substance Use Disorders is complicated. A specific screening tool, such as the World Health Organization Adult ADHD Self Report Scale Screener can be the first step in identifying the condition. Recently, the screener has been revised because the Diagnostic and Statistical Manual of Mental Disorders, Fifth edition, made some changes to the criteria for Attention Deficit Hyperactivity Disorder. This study compared the screeners based upon the Fourth and Fifth edition of the Manual. One hundred and forty patients, including seventy with Attention Deficit Hyperactivity Disorder, completed both screeners, independent from a clinical diagnostic interview. The sensitivity, specificity, and predictive values were calculated based on four different scoring methods: a categorical score of three or four positive answers, and a dimensional score of twelve or fourteen. Both screening instruments appeared to perform equally without significant differences between them, no matter which scoring system was used. However, the only satisfactory result was obtained using the dimensional scoring with a cutoff of 12, providing a sensitivity and negative predictive value above 80%. This is a lower cut off than recommended in community and clinic samples. It is possible that the cut off of the screener may need to be adjusted depending on the circumstances within which it is used.

Entities:  

Keywords:  Adult ADHD; DSM IV screener; DSM-5 screener; Substance use disorders

Mesh:

Year:  2018        PMID: 29270886     DOI: 10.1007/s11126-017-9553-4

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN: 0033-2720


  12 in total

1.  Validity of the World Health Organization Adult ADHD Self-Report Scale (ASRS) Screener in a representative sample of health plan members.

Authors:  Ronald C Kessler; Lenard A Adler; Michael J Gruber; Chaitanya A Sarawate; Thomas Spencer; David L Van Brunt
Journal:  Int J Methods Psychiatr Res       Date:  2007       Impact factor: 4.035

Review 2.  Substance abuse in patients with attention-deficit hyperactivity disorder : therapeutic implications.

Authors:  Howard Schubiner
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

3.  A controlled study of nortriptyline in children and adolescents with attention deficit hyperactivity disorder.

Authors:  J B Prince; T E Wilens; J Biederman; T J Spencer; R Millstein; D A Polisner; J Q Bostic
Journal:  J Child Adolesc Psychopharmacol       Date:  2000       Impact factor: 2.576

4.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

5.  Questioning the specificity of ASRS-v1.1 to accurately detect ADHD in substance abusing populations.

Authors:  Jean-Pierre Chiasson; Katherine Stavro; Élie Rizkallah; Luc Lapierre; Maxime Dussault; Louis Legault; Stéphane Potvin
Journal:  J Atten Disord       Date:  2011-11-02       Impact factor: 3.256

6.  The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population.

Authors:  Ronald C Kessler; Lenard Adler; Minnie Ames; Olga Demler; Steve Faraone; Eva Hiripi; Mary J Howes; Robert Jin; Kristina Secnik; Thomas Spencer; T Bedirhan Ustun; Ellen E Walters
Journal:  Psychol Med       Date:  2005-02       Impact factor: 7.723

7.  Adult ADHD Self-Report Scale (ASRS-v1.1) symptom checklist in patients with substance use disorders.

Authors:  Constanza Daigre Blanco; J A Ramos-Quiroga; S Valero; R Bosch; C Roncero; B Gonzalvo; M Nogueira
Journal:  Actas Esp Psiquiatr       Date:  2009 Nov-Dec       Impact factor: 1.196

Review 8.  Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues.

Authors:  Timothy E Wilens
Journal:  Psychiatr Clin North Am       Date:  2004-06

9.  Validity of the Adult ADHD Self-Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients.

Authors:  Geurt van de Glind; Wim van den Brink; Maarten W J Koeter; Pieter-Jan Carpentier; Katelijne van Emmerik-van Oortmerssen; Sharlene Kaye; Arvid Skutle; Eli-Torild H Bu; Johan Franck; Maija Konstenius; Franz Moggi; Geert Dom; Sofie Verspreet; Zsolt Demetrovics; Máté Kapitány-Fövény; Melina Fatséas; Marc Auriacombe; Arild Schillinger; Andrea Seitz; Brian Johnson; Stephen V Faraone; J Antoni Ramos-Quiroga; Miguel Casas; Steve Allsop; Susan Carruthers; Csaba Barta; Robert A Schoevers; Frances R Levin
Journal:  Drug Alcohol Depend       Date:  2013-05-06       Impact factor: 4.492

Review 10.  Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis.

Authors:  Viktória Simon; Pál Czobor; Sára Bálint; Agnes Mészáros; István Bitter
Journal:  Br J Psychiatry       Date:  2009-03       Impact factor: 9.319

View more
  3 in total

1.  [ADHD screening in alcohol dependent subjects : Psychometric characteristics of ADHD self-report scale and Wender Utah Rating Scale short form].

Authors:  Mathias Luderer; Nurcihan Kaplan-Wickel; Christian Sick; Agnes Richter; Iris Reinhard; Falk Kiefer; Tillmann Weber
Journal:  Nervenarzt       Date:  2019-11       Impact factor: 1.214

2.  Comorbidity of migraine with ADHD in adults.

Authors:  Thomas Folkmann Hansen; Louise K Hoeffding; Lisette Kogelman; Thilde Marie Haspang; Henrik Ullum; Erik Sørensen; Christian Erikstrup; Ole Birger Pedersen; Kaspar René Nielsen; Henrik Hjalgrim; Helene M Paarup; Thomas Werge; Kristoffer Burgdorf
Journal:  BMC Neurol       Date:  2018-10-16       Impact factor: 2.474

3.  Identification of Brain Regions with Enhanced Functional Connectivity with the Cerebellum Region in Children with Attention Deficit Hyperactivity Disorder: A Resting-State fMRI Study.

Authors:  Li Ding; Gaofeng Pang
Journal:  Int J Gen Med       Date:  2021-05-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.